

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.75128104 |
| 2 | sarcomere organization (GO:0045214) | 5.62599882 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.59123533 |
| 4 | mannose metabolic process (GO:0006013) | 5.47650255 |
| 5 | cardiac myofibril assembly (GO:0055003) | 5.39941198 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.23303702 |
| 7 | myofibril assembly (GO:0030239) | 4.82975687 |
| 8 | tricarboxylic acid cycle (GO:0006099) | 4.79196526 |
| 9 | carnitine shuttle (GO:0006853) | 4.69010321 |
| 10 | cardiac muscle contraction (GO:0060048) | 4.58500060 |
| 11 | aspartate family amino acid catabolic process (GO:0009068) | 4.43560292 |
| 12 | lysine catabolic process (GO:0006554) | 4.41525654 |
| 13 | lysine metabolic process (GO:0006553) | 4.41525654 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.39373959 |
| 15 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.30528895 |
| 16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.29921215 |
| 17 | negative regulation of cell size (GO:0045792) | 4.29089976 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 4.26819352 |
| 19 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.21770075 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 4.21654129 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.16887912 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.16779729 |
| 23 | fatty acid transmembrane transport (GO:1902001) | 4.15826969 |
| 24 | creatine metabolic process (GO:0006600) | 4.13859080 |
| 25 | apoptotic process involved in morphogenesis (GO:0060561) | 4.12223355 |
| 26 | plasma membrane repair (GO:0001778) | 3.99018542 |
| 27 | actin-myosin filament sliding (GO:0033275) | 3.96423187 |
| 28 | muscle filament sliding (GO:0030049) | 3.96423187 |
| 29 | cell communication involved in cardiac conduction (GO:0086065) | 3.94005727 |
| 30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.91918019 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.90131245 |
| 32 | adult heart development (GO:0007512) | 3.86258349 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.84070549 |
| 34 | NADH metabolic process (GO:0006734) | 3.81781246 |
| 35 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.74282056 |
| 36 | actomyosin structure organization (GO:0031032) | 3.69284032 |
| 37 | cardiac muscle cell development (GO:0055013) | 3.69240453 |
| 38 | thymic T cell selection (GO:0045061) | 3.64858457 |
| 39 | carnitine transmembrane transport (GO:1902603) | 3.62425877 |
| 40 | regulation of skeletal muscle contraction (GO:0014819) | 3.61938047 |
| 41 | striated muscle contraction (GO:0006941) | 3.60438835 |
| 42 | carnitine transport (GO:0015879) | 3.60198767 |
| 43 | amino-acid betaine transport (GO:0015838) | 3.60198767 |
| 44 | cell communication by electrical coupling (GO:0010644) | 3.56600322 |
| 45 | histone H4 deacetylation (GO:0070933) | 3.55736271 |
| 46 | regulation of membrane repolarization (GO:0060306) | 3.55353503 |
| 47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.53934288 |
| 48 | fatty acid beta-oxidation (GO:0006635) | 3.53784695 |
| 49 | short-chain fatty acid metabolic process (GO:0046459) | 3.49426424 |
| 50 | regulation of ARF GTPase activity (GO:0032312) | 3.48338751 |
| 51 | cardiac cell development (GO:0055006) | 3.45178203 |
| 52 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.44728948 |
| 53 | cardiac muscle hypertrophy (GO:0003300) | 3.44234723 |
| 54 | heart trabecula formation (GO:0060347) | 3.42836843 |
| 55 | semaphorin-plexin signaling pathway (GO:0071526) | 3.41799071 |
| 56 | regulation of the force of heart contraction (GO:0002026) | 3.41037239 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.40891304 |
| 58 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.38065326 |
| 59 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.36256298 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.34202083 |
| 61 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.33362971 |
| 62 | positive thymic T cell selection (GO:0045059) | 3.32789705 |
| 63 | regulation of coenzyme metabolic process (GO:0051196) | 3.30048282 |
| 64 | regulation of cofactor metabolic process (GO:0051193) | 3.30048282 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.27503191 |
| 66 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.27171769 |
| 67 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.26813170 |
| 68 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.26663115 |
| 69 | striated muscle hypertrophy (GO:0014897) | 3.26639475 |
| 70 | proline biosynthetic process (GO:0006561) | 3.26024341 |
| 71 | regulation of fatty acid oxidation (GO:0046320) | 3.24974746 |
| 72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.24725991 |
| 73 | actin-mediated cell contraction (GO:0070252) | 3.24130856 |
| 74 | modulation by virus of host process (GO:0019054) | 3.23674379 |
| 75 | regulation of striated muscle contraction (GO:0006942) | 3.23420346 |
| 76 | regulation of relaxation of muscle (GO:1901077) | 3.22556022 |
| 77 | oxaloacetate metabolic process (GO:0006107) | 3.22450398 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.21707577 |
| 79 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.20341285 |
| 80 | tricarboxylic acid metabolic process (GO:0072350) | 3.19396100 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.17986714 |
| 82 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.17724738 |
| 83 | biotin metabolic process (GO:0006768) | 3.16362451 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16355237 |
| 85 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.15756323 |
| 86 | positive regulation of histone deacetylation (GO:0031065) | 3.15411096 |
| 87 | cellular ketone body metabolic process (GO:0046950) | 3.14836513 |
| 88 | histone H3 deacetylation (GO:0070932) | 3.14321158 |
| 89 | potassium ion import (GO:0010107) | 3.10736536 |
| 90 | fatty acid catabolic process (GO:0009062) | 3.10252476 |
| 91 | regulation of sequestering of triglyceride (GO:0010889) | 3.10223337 |
| 92 | regulation of cell communication by electrical coupling (GO:0010649) | 3.08720160 |
| 93 | activation of MAPKKK activity (GO:0000185) | 3.08126125 |
| 94 | fatty acid oxidation (GO:0019395) | 3.01966181 |
| 95 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.01877926 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.01809350 |
| 97 | activation of Rac GTPase activity (GO:0032863) | 3.01221690 |
| 98 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.01059825 |
| 99 | COPI coating of Golgi vesicle (GO:0048205) | 3.00003689 |
| 100 | Golgi transport vesicle coating (GO:0048200) | 3.00003689 |
| 101 | muscle tissue morphogenesis (GO:0060415) | 2.99237550 |
| 102 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.98919841 |
| 103 | glyoxylate metabolic process (GO:0046487) | 2.98084333 |
| 104 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97737830 |
| 105 | L-phenylalanine metabolic process (GO:0006558) | 2.96352839 |
| 106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96352839 |
| 107 | protein retention in ER lumen (GO:0006621) | 2.96236492 |
| 108 | modulation by symbiont of host cellular process (GO:0044068) | 2.95595687 |
| 109 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.95259480 |
| 110 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.95259480 |
| 111 | modulation by symbiont of host immune response (GO:0052553) | 2.95259480 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 2.95259480 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 2.95259480 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.95259480 |
| 115 | succinate metabolic process (GO:0006105) | 2.95184068 |
| 116 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.95002406 |
| 117 | quaternary ammonium group transport (GO:0015697) | 2.94698087 |
| 118 | lipid oxidation (GO:0034440) | 2.94480109 |
| 119 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.94377276 |
| 120 | cardiac muscle cell action potential (GO:0086001) | 2.92695181 |
| 121 | adherens junction assembly (GO:0034333) | 2.92684173 |
| 122 | sodium ion export (GO:0071436) | 2.91129648 |
| 123 | activation of JUN kinase activity (GO:0007257) | 2.90489971 |
| 124 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.90383161 |
| 125 | negative regulation of cell killing (GO:0031342) | 2.90383161 |
| 126 | GDP-mannose metabolic process (GO:0019673) | 2.88862490 |
| 127 | snRNA metabolic process (GO:0016073) | 2.87816424 |
| 128 | branched-chain amino acid catabolic process (GO:0009083) | 2.86781241 |
| 129 | focal adhesion assembly (GO:0048041) | 2.85068891 |
| 130 | cell-substrate adherens junction assembly (GO:0007045) | 2.85068891 |
| 131 | regulation of histone H3-K27 methylation (GO:0061085) | 2.84416261 |
| 132 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.84163547 |
| 133 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.84163547 |
| 134 | negative regulation of potassium ion transport (GO:0043267) | 2.83895197 |
| 135 | negative regulation of myotube differentiation (GO:0010832) | 2.82577694 |
| 136 | regulation of sarcomere organization (GO:0060297) | 2.82549153 |
| 137 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.82399512 |
| 138 | L-phenylalanine catabolic process (GO:0006559) | 2.81282788 |
| 139 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.81282788 |
| 140 | maternal placenta development (GO:0001893) | 2.80971390 |
| 141 | cardiac conduction (GO:0061337) | 2.80613263 |
| 142 | monocarboxylic acid catabolic process (GO:0072329) | 2.80064192 |
| 143 | T cell selection (GO:0045058) | 2.79772718 |
| 144 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.78993906 |
| 145 | relaxation of cardiac muscle (GO:0055119) | 2.78929611 |
| 146 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.77543562 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.77506505 |
| 148 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75579851 |
| 149 | regulation of heart rate (GO:0002027) | 2.74469195 |
| 150 | branched-chain amino acid metabolic process (GO:0009081) | 2.74027390 |
| 151 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.73478954 |
| 152 | regulation of cardiac muscle contraction (GO:0055117) | 2.72296598 |
| 153 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.72071167 |
| 154 | response to peptidoglycan (GO:0032494) | 2.71699255 |
| 155 | muscle hypertrophy (GO:0014896) | 2.71576310 |
| 156 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.71490614 |
| 157 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.71148961 |
| 158 | apoptotic process involved in development (GO:1902742) | 2.69308628 |
| 159 | muscle hypertrophy in response to stress (GO:0003299) | 2.69167850 |
| 160 | positive regulation of protein deacetylation (GO:0090312) | 2.63402350 |
| 161 | barbed-end actin filament capping (GO:0051016) | 2.60849504 |
| 162 | cellular response to virus (GO:0098586) | 2.60648508 |
| 163 | regulation of monocyte differentiation (GO:0045655) | 2.60552940 |
| 164 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.58681863 |
| 165 | pinocytosis (GO:0006907) | 2.58543203 |
| 166 | UV protection (GO:0009650) | 2.56734423 |
| 167 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.55845828 |
| 168 | retrograde transport, endosome to Golgi (GO:0042147) | 2.55694422 |
| 169 | pentose-phosphate shunt (GO:0006098) | 2.55427672 |
| 170 | regulation of chromatin binding (GO:0035561) | 2.54938898 |
| 171 | snRNA processing (GO:0016180) | 2.54637746 |
| 172 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.54616844 |
| 173 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.54474878 |
| 174 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54120662 |
| 175 | atrioventricular valve morphogenesis (GO:0003181) | 2.53607746 |
| 176 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.53006203 |
| 177 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51084729 |
| 178 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50919844 |
| 179 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.50739969 |
| 180 | negative thymic T cell selection (GO:0045060) | 2.49514866 |
| 181 | negative regulation of viral release from host cell (GO:1902187) | 2.49501522 |
| 182 | negative regulation of interleukin-2 production (GO:0032703) | 2.48476940 |
| 183 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.47010082 |
| 184 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.46037910 |
| 185 | cell-cell junction maintenance (GO:0045217) | 2.45642845 |
| 186 | positive regulation of nuclease activity (GO:0032075) | 2.45257339 |
| 187 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44244822 |
| 188 | response to laminar fluid shear stress (GO:0034616) | 2.43261489 |
| 189 | regulation of defense response to virus by virus (GO:0050690) | 2.43074488 |
| 190 | detection of bacterium (GO:0016045) | 2.42676789 |
| 191 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.41377416 |
| 192 | leukocyte aggregation (GO:0070486) | 2.41037130 |
| 193 | regulation of early endosome to late endosome transport (GO:2000641) | 2.40646034 |
| 194 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.40344058 |
| 195 | embryonic process involved in female pregnancy (GO:0060136) | 2.40306382 |
| 196 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.38682632 |
| 197 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.37627863 |
| 198 | mRNA stabilization (GO:0048255) | 2.36300472 |
| 199 | RNA stabilization (GO:0043489) | 2.36300472 |
| 200 | regulation of ARF protein signal transduction (GO:0032012) | 2.35210373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.52934794 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.35721839 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.16726610 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09487777 |
| 5 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.06449868 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.94059288 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.92152058 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.70629239 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66082150 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.34187388 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27705530 |
| 12 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.24776010 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.24776010 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20317293 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.20055272 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19355586 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.07317830 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07047035 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04778060 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04427778 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04043994 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97996172 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93864700 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88953269 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85016303 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.84784094 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.83679935 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80507393 |
| 29 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.79345722 |
| 30 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.78612365 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78310977 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77735446 |
| 33 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.71699129 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69024188 |
| 35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.67412813 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.66413523 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.66284592 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66255386 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.63240491 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62884361 |
| 41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.61928788 |
| 42 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.61517533 |
| 43 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58176461 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.56392119 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56324751 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.52411384 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51327880 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50770209 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50766661 |
| 50 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.50278534 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49590416 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.49414657 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49362629 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48231744 |
| 55 | * P68_20966046_ChIP-Seq_HELA_Human | 1.47435386 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45847154 |
| 57 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44994244 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43800735 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.43561413 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41913336 |
| 61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40167825 |
| 62 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.39787569 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39063600 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37972730 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37544948 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37143925 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35735190 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32455040 |
| 69 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29248150 |
| 70 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28712694 |
| 71 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.28583784 |
| 72 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.27450771 |
| 73 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.24674131 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23898526 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23890735 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23573852 |
| 77 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22919120 |
| 78 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.21911874 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21559544 |
| 80 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21328626 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21280812 |
| 82 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21261529 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20716759 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20341358 |
| 85 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20038297 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19706251 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18523982 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17420277 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16968658 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16907823 |
| 91 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.15311001 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14922356 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14912598 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14316165 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13905425 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13802996 |
| 97 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13302268 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12576415 |
| 99 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12547129 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12481645 |
| 101 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12403828 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11026207 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10951726 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09702021 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09637197 |
| 106 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09560374 |
| 107 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09560374 |
| 108 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09355849 |
| 109 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09175981 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08890613 |
| 111 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08410036 |
| 112 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07252866 |
| 113 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07252215 |
| 114 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07037386 |
| 115 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06859742 |
| 116 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06239243 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05671982 |
| 118 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05445199 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05089925 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04788982 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04416152 |
| 122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04377686 |
| 123 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03824433 |
| 124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03685933 |
| 125 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03066181 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02642581 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02466906 |
| 128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01782277 |
| 129 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01056065 |
| 130 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00667028 |
| 131 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00253805 |
| 132 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.99775570 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99761787 |
| 134 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.99207671 |
| 135 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99002953 |
| 136 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98896441 |
| 137 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98212100 |
| 138 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96861890 |
| 139 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96787781 |
| 140 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96482532 |
| 141 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95653691 |
| 142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94269583 |
| 143 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.94008559 |
| 144 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.93540635 |
| 145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93405476 |
| 146 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92736752 |
| 147 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92428729 |
| 148 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91547204 |
| 149 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.90854539 |
| 150 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88508340 |
| 151 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87826734 |
| 152 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87761061 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86601965 |
| 154 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85212734 |
| 155 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84154640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.60599562 |
| 2 | MP0003646_muscle_fatigue | 4.55023931 |
| 3 | MP0000751_myopathy | 4.34308628 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.99025472 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.98713788 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.61579899 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.41060291 |
| 8 | MP0003172_abnormal_lysosome_physiology | 3.28984911 |
| 9 | MP0005330_cardiomyopathy | 3.13853527 |
| 10 | MP0003436_decreased_susceptibility_to | 3.12008276 |
| 11 | MP0009278_abnormal_bone_marrow | 3.11817289 |
| 12 | MP0008260_abnormal_autophagy | 3.10319901 |
| 13 | MP0001849_ear_inflammation | 2.95182858 |
| 14 | MP0000749_muscle_degeneration | 2.94220773 |
| 15 | MP0005360_urolithiasis | 2.78665612 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.59537094 |
| 17 | MP0004130_abnormal_muscle_cell | 2.55532461 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.37311178 |
| 19 | MP0003303_peritoneal_inflammation | 2.32581435 |
| 20 | MP0004858_abnormal_nervous_system | 2.30274319 |
| 21 | MP0002972_abnormal_cardiac_muscle | 2.26409102 |
| 22 | MP0002269_muscular_atrophy | 2.21492506 |
| 23 | MP0005076_abnormal_cell_differentiation | 2.20324286 |
| 24 | MP0000747_muscle_weakness | 2.19665455 |
| 25 | MP0000678_abnormal_parathyroid_gland | 2.18368923 |
| 26 | MP0005620_abnormal_muscle_contractility | 2.15213855 |
| 27 | MP0008775_abnormal_heart_ventricle | 2.15004332 |
| 28 | MP0002822_catalepsy | 2.12415523 |
| 29 | MP0004233_abnormal_muscle_weight | 2.10587259 |
| 30 | MP0010630_abnormal_cardiac_muscle | 2.02541655 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 2.00582567 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.97669942 |
| 33 | MP0000750_abnormal_muscle_regeneration | 1.95643708 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.94101878 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.92900684 |
| 36 | MP0004043_abnormal_pH_regulation | 1.92338596 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.91543681 |
| 38 | MP0004947_skin_inflammation | 1.88112942 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.85417275 |
| 40 | MP0004085_abnormal_heartbeat | 1.85055069 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.83949800 |
| 42 | MP0005365_abnormal_bile_salt | 1.83432272 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.82859081 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.82859081 |
| 45 | MP0004484_altered_response_of | 1.78077130 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.76506424 |
| 47 | MP0001873_stomach_inflammation | 1.75418727 |
| 48 | MP0006138_congestive_heart_failure | 1.74103538 |
| 49 | MP0000858_altered_metastatic_potential | 1.70640942 |
| 50 | MP0002249_abnormal_larynx_morphology | 1.70196139 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.69781398 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.68880811 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.68718108 |
| 54 | MP0005670_abnormal_white_adipose | 1.59510930 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.54406415 |
| 56 | MP0005369_muscle_phenotype | 1.52280790 |
| 57 | MP0005025_abnormal_response_to | 1.52142674 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.52121619 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.48995160 |
| 60 | MP0001348_abnormal_lacrimal_gland | 1.47849500 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47772338 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.47217001 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.44675657 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.44675657 |
| 65 | MP0002419_abnormal_innate_immunity | 1.41260930 |
| 66 | MP0005332_abnormal_amino_acid | 1.41074280 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.38762253 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.37908199 |
| 69 | MP0002332_abnormal_exercise_endurance | 1.36902740 |
| 70 | MP0009840_abnormal_foam_cell | 1.36100574 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34983583 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.34380454 |
| 73 | MP0003279_aneurysm | 1.34248934 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.33643067 |
| 75 | MP0000685_abnormal_immune_system | 1.33576362 |
| 76 | MP0004381_abnormal_hair_follicle | 1.32039087 |
| 77 | MP0002398_abnormal_bone_marrow | 1.30124886 |
| 78 | MP0002234_abnormal_pharynx_morphology | 1.29852248 |
| 79 | MP0002796_impaired_skin_barrier | 1.29842584 |
| 80 | MP0001800_abnormal_humoral_immune | 1.29547340 |
| 81 | MP0001819_abnormal_immune_cell | 1.29209091 |
| 82 | MP0002254_reproductive_system_inflammat | 1.28803606 |
| 83 | MP0002420_abnormal_adaptive_immunity | 1.28751313 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.28615518 |
| 85 | MP0000703_abnormal_thymus_morphology | 1.26604346 |
| 86 | MP0003252_abnormal_bile_duct | 1.25593906 |
| 87 | MP0005083_abnormal_biliary_tract | 1.24054696 |
| 88 | MP0002723_abnormal_immune_serum | 1.22094997 |
| 89 | MP0010155_abnormal_intestine_physiology | 1.20990520 |
| 90 | MP0005501_abnormal_skin_physiology | 1.20825074 |
| 91 | MP0001533_abnormal_skeleton_physiology | 1.19746388 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.18115258 |
| 93 | MP0002933_joint_inflammation | 1.17600119 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 1.16983882 |
| 95 | MP0003283_abnormal_digestive_organ | 1.16906162 |
| 96 | MP0000490_abnormal_crypts_of | 1.16834614 |
| 97 | MP0005387_immune_system_phenotype | 1.16604760 |
| 98 | MP0001790_abnormal_immune_system | 1.16604760 |
| 99 | MP0003011_delayed_dark_adaptation | 1.16588297 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 1.16365036 |
| 101 | MP0000716_abnormal_immune_system | 1.15792573 |
| 102 | MP0003300_gastrointestinal_ulcer | 1.14563557 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 1.14524662 |
| 104 | MP0005409_darkened_coat_color | 1.14507720 |
| 105 | MP0002127_abnormal_cardiovascular_syste | 1.14243598 |
| 106 | MP0001666_abnormal_nutrient_absorption | 1.13919633 |
| 107 | MP0001835_abnormal_antigen_presentation | 1.11000317 |
| 108 | MP0002429_abnormal_blood_cell | 1.10509520 |
| 109 | MP0005671_abnormal_response_to | 1.07180564 |
| 110 | MP0002722_abnormal_immune_system | 1.07113544 |
| 111 | MP0002405_respiratory_system_inflammati | 1.07005018 |
| 112 | MP0002118_abnormal_lipid_homeostasis | 1.05856754 |
| 113 | MP0010329_abnormal_lipoprotein_level | 1.03457222 |
| 114 | MP0005451_abnormal_body_composition | 1.02538247 |
| 115 | MP0003828_pulmonary_edema | 1.01899044 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 1.01644781 |
| 117 | MP0004510_myositis | 1.01173194 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 1.00246382 |
| 119 | MP0000733_abnormal_muscle_development | 1.00144705 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.99626817 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 0.99583401 |
| 122 | MP0004859_abnormal_synaptic_plasticity | 0.98842654 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.98616233 |
| 124 | MP0003705_abnormal_hypodermis_morpholog | 0.96194000 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.95531362 |
| 126 | MP0005266_abnormal_metabolism | 0.94386906 |
| 127 | MP0009931_abnormal_skin_appearance | 0.93840531 |
| 128 | MP0001853_heart_inflammation | 0.92935888 |
| 129 | MP0002909_abnormal_adrenal_gland | 0.92781703 |
| 130 | MP0003329_amyloid_beta_deposits | 0.92746637 |
| 131 | MP0003195_calcinosis | 0.91104433 |
| 132 | MP0003091_abnormal_cell_migration | 0.90902407 |
| 133 | MP0002971_abnormal_brown_adipose | 0.90223202 |
| 134 | MP0005621_abnormal_cell_physiology | 0.89748462 |
| 135 | MP0003111_abnormal_nucleus_morphology | 0.88796366 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.88110942 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.85918936 |
| 138 | MP0010030_abnormal_orbit_morphology | 0.84445527 |
| 139 | MP0001730_embryonic_growth_arrest | 0.84435404 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.84132403 |
| 141 | MP0002229_neurodegeneration | 0.84110217 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.83507057 |
| 143 | MP0005319_abnormal_enzyme/_coenzyme | 0.82807213 |
| 144 | MP0000266_abnormal_heart_morphology | 0.82730004 |
| 145 | MP0005390_skeleton_phenotype | 0.82528908 |
| 146 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81264431 |
| 147 | MP0003866_abnormal_defecation | 0.81147384 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.80862889 |
| 149 | MP0000313_abnormal_cell_death | 0.79254983 |
| 150 | MP0005253_abnormal_eye_physiology | 0.78624206 |
| 151 | MP0000537_abnormal_urethra_morphology | 0.78383634 |
| 152 | MP0000003_abnormal_adipose_tissue | 0.78198665 |
| 153 | MP0001958_emphysema | 0.77386249 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.76474884 |
| 155 | MP0001663_abnormal_digestive_system | 0.75513713 |
| 156 | MP0008569_lethality_at_weaning | 0.75338372 |
| 157 | MP0001845_abnormal_inflammatory_respons | 0.74719951 |
| 158 | MP0005535_abnormal_body_temperature | 0.74001419 |
| 159 | MP0004270_analgesia | 0.73442283 |
| 160 | MP0000681_abnormal_thyroid_gland | 0.73364549 |
| 161 | MP0000013_abnormal_adipose_tissue | 0.73261475 |
| 162 | MP0000767_abnormal_smooth_muscle | 0.73001697 |
| 163 | MP0005165_increased_susceptibility_to | 0.72706755 |
| 164 | MP0005023_abnormal_wound_healing | 0.72542827 |
| 165 | MP0002970_abnormal_white_adipose | 0.71641325 |
| 166 | MP0002060_abnormal_skin_morphology | 0.70778822 |
| 167 | MP0002019_abnormal_tumor_incidence | 0.70327281 |
| 168 | MP0002090_abnormal_vision | 0.69918106 |
| 169 | MP0002132_abnormal_respiratory_system | 0.69778362 |
| 170 | MP0002148_abnormal_hypersensitivity_rea | 0.69293310 |
| 171 | MP0004885_abnormal_endolymph | 0.68829786 |
| 172 | MP0003191_abnormal_cellular_cholesterol | 0.68238440 |
| 173 | MP0000609_abnormal_liver_physiology | 0.65758377 |
| 174 | MP0005386_behavior/neurological_phenoty | 0.65565576 |
| 175 | MP0004924_abnormal_behavior | 0.65565576 |
| 176 | MP0005187_abnormal_penis_morphology | 0.64282502 |
| 177 | MP0003656_abnormal_erythrocyte_physiolo | 0.60795876 |
| 178 | MP0004019_abnormal_vitamin_homeostasis | 0.59520622 |
| 179 | MP0005167_abnormal_blood-brain_barrier | 0.58824440 |
| 180 | MP0003635_abnormal_synaptic_transmissio | 0.58726494 |
| 181 | MP0008874_decreased_physiological_sensi | 0.58725154 |
| 182 | MP0009780_abnormal_chondrocyte_physiolo | 0.58355785 |
| 183 | MP0002272_abnormal_nervous_system | 0.57442050 |
| 184 | MP0002064_seizures | 0.54503197 |
| 185 | MP0005195_abnormal_posterior_eye | 0.53693099 |
| 186 | MP0000920_abnormal_myelination | 0.51587485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.24869653 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.41536989 |
| 3 | Ventricular tachycardia (HP:0004756) | 4.95903739 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.89659152 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.87599444 |
| 6 | Myoglobinuria (HP:0002913) | 4.83303564 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.73992153 |
| 8 | Atrial fibrillation (HP:0005110) | 4.43332679 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.39549040 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.35603848 |
| 11 | Syncope (HP:0001279) | 4.17485510 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 4.13033716 |
| 13 | Bundle branch block (HP:0011710) | 3.98248661 |
| 14 | Supraventricular tachycardia (HP:0004755) | 3.96661160 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 3.86883901 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 3.83310543 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.76619179 |
| 18 | Prolonged QT interval (HP:0001657) | 3.72930014 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.71294858 |
| 20 | Broad face (HP:0000283) | 3.70488480 |
| 21 | J-shaped sella turcica (HP:0002680) | 3.62616402 |
| 22 | Lipoatrophy (HP:0100578) | 3.56183608 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.49805696 |
| 24 | Subaortic stenosis (HP:0001682) | 3.49805696 |
| 25 | Palpitations (HP:0001962) | 3.47466016 |
| 26 | Difficulty running (HP:0009046) | 3.46525762 |
| 27 | Ketoacidosis (HP:0001993) | 3.45471310 |
| 28 | Ventricular fibrillation (HP:0001663) | 3.41593557 |
| 29 | Central scotoma (HP:0000603) | 3.39504706 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.31736719 |
| 31 | Cervical subluxation (HP:0003308) | 3.28549751 |
| 32 | Heart block (HP:0012722) | 3.26529940 |
| 33 | Stridor (HP:0010307) | 3.25198317 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.24373034 |
| 35 | Atrioventricular block (HP:0001678) | 3.22726449 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 3.21323901 |
| 37 | Dilated cardiomyopathy (HP:0001644) | 3.19459221 |
| 38 | Hyperacusis (HP:0010780) | 3.17649152 |
| 39 | Ketosis (HP:0001946) | 3.14745053 |
| 40 | Hyperglycinuria (HP:0003108) | 3.08070431 |
| 41 | Biconcave vertebral bodies (HP:0004586) | 3.05818198 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.97895840 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 2.93885145 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.86966198 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.86120652 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.81950475 |
| 47 | Dysmetric saccades (HP:0000641) | 2.81133635 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.80822958 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.78783681 |
| 50 | Increased connective tissue (HP:0009025) | 2.75538002 |
| 51 | Hyperammonemia (HP:0001987) | 2.73223969 |
| 52 | Thin bony cortex (HP:0002753) | 2.72201274 |
| 53 | Muscle stiffness (HP:0003552) | 2.71184920 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.70808064 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70808064 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70520855 |
| 57 | Colitis (HP:0002583) | 2.70351188 |
| 58 | Myotonia (HP:0002486) | 2.69595480 |
| 59 | Abnormal EKG (HP:0003115) | 2.62323290 |
| 60 | Abnormality of the thoracic spine (HP:0100711) | 2.61118379 |
| 61 | Broad distal phalanx of finger (HP:0009836) | 2.60171763 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.59374231 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59374231 |
| 64 | Cellulitis (HP:0100658) | 2.56698404 |
| 65 | Ulnar bowing (HP:0003031) | 2.49830338 |
| 66 | Upper limb amyotrophy (HP:0009129) | 2.47330275 |
| 67 | Distal upper limb amyotrophy (HP:0007149) | 2.47330275 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43476822 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43476822 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43476822 |
| 71 | Obstructive lung disease (HP:0006536) | 2.41468046 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41468046 |
| 73 | Scotoma (HP:0000575) | 2.40640499 |
| 74 | Congenital stationary night blindness (HP:0007642) | 2.38530436 |
| 75 | Cholelithiasis (HP:0001081) | 2.38477058 |
| 76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37759111 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.37759111 |
| 78 | Difficulty climbing stairs (HP:0003551) | 2.37240312 |
| 79 | Gout (HP:0001997) | 2.37009237 |
| 80 | Hypertensive crisis (HP:0100735) | 2.36602982 |
| 81 | Increased IgE level (HP:0003212) | 2.35609157 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.35376272 |
| 83 | Truncus arteriosus (HP:0001660) | 2.33075199 |
| 84 | Ragged-red muscle fibers (HP:0003200) | 2.30769011 |
| 85 | Left ventricular hypertrophy (HP:0001712) | 2.30740197 |
| 86 | Joint stiffness (HP:0001387) | 2.29850114 |
| 87 | Long palpebral fissure (HP:0000637) | 2.28676765 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27218868 |
| 89 | Myopathic facies (HP:0002058) | 2.24523839 |
| 90 | Increased muscle lipid content (HP:0009058) | 2.24399590 |
| 91 | Metaphyseal cupping (HP:0003021) | 2.22952767 |
| 92 | Seborrheic dermatitis (HP:0001051) | 2.22089608 |
| 93 | Thoracic kyphosis (HP:0002942) | 2.20716145 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.18384561 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 2.18110362 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 2.17992089 |
| 97 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.16523154 |
| 98 | Atelectasis (HP:0100750) | 2.16389214 |
| 99 | Achilles tendon contracture (HP:0001771) | 2.15694878 |
| 100 | Reticulocytosis (HP:0001923) | 2.15177209 |
| 101 | Increased variability in muscle fiber diameter (HP:0003557) | 2.15126635 |
| 102 | Abnormal gallbladder morphology (HP:0012437) | 2.14810387 |
| 103 | Protrusio acetabuli (HP:0003179) | 2.14256924 |
| 104 | Easy fatigability (HP:0003388) | 2.13824103 |
| 105 | Disproportionate tall stature (HP:0001519) | 2.13132063 |
| 106 | Hyperglycinemia (HP:0002154) | 2.09775290 |
| 107 | Vertebral compression fractures (HP:0002953) | 2.09560772 |
| 108 | Cerebral edema (HP:0002181) | 2.07694218 |
| 109 | EMG: neuropathic changes (HP:0003445) | 2.06608627 |
| 110 | Abnormality of the fingertips (HP:0001211) | 2.06516748 |
| 111 | Metabolic acidosis (HP:0001942) | 2.03575715 |
| 112 | Spinal cord lesions (HP:0100561) | 2.03023600 |
| 113 | Syringomyelia (HP:0003396) | 2.03023600 |
| 114 | Mitral regurgitation (HP:0001653) | 2.02328548 |
| 115 | Hamartoma of the eye (HP:0010568) | 2.01801658 |
| 116 | Pheochromocytoma (HP:0002666) | 2.01478509 |
| 117 | Loss of speech (HP:0002371) | 2.01458063 |
| 118 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00978481 |
| 119 | Nuclear cataract (HP:0100018) | 1.98035666 |
| 120 | Testicular atrophy (HP:0000029) | 1.97613798 |
| 121 | Acute encephalopathy (HP:0006846) | 1.96357354 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.96219152 |
| 123 | Inflammation of the large intestine (HP:0002037) | 1.95946573 |
| 124 | Pointed chin (HP:0000307) | 1.94793230 |
| 125 | Emphysema (HP:0002097) | 1.93928029 |
| 126 | Athetosis (HP:0002305) | 1.93808243 |
| 127 | Hepatic necrosis (HP:0002605) | 1.91890727 |
| 128 | Flat acetabular roof (HP:0003180) | 1.91730515 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.91721238 |
| 130 | Deformed sella turcica (HP:0002681) | 1.90941795 |
| 131 | Polygenic inheritance (HP:0010982) | 1.89483507 |
| 132 | Cholecystitis (HP:0001082) | 1.88810056 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 1.88810056 |
| 134 | Flattened epiphyses (HP:0003071) | 1.88004107 |
| 135 | Abnormality of macrophages (HP:0004311) | 1.87718420 |
| 136 | Selective tooth agenesis (HP:0001592) | 1.87386994 |
| 137 | Recurrent abscess formation (HP:0002722) | 1.87121925 |
| 138 | Pigmentary retinal degeneration (HP:0001146) | 1.86814700 |
| 139 | Xanthomatosis (HP:0000991) | 1.85405933 |
| 140 | Abnormality of the Achilles tendon (HP:0005109) | 1.84428614 |
| 141 | Limb-girdle muscle atrophy (HP:0003797) | 1.84323642 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.84199165 |
| 143 | Hyperlipoproteinemia (HP:0010980) | 1.84001711 |
| 144 | Gastrointestinal dysmotility (HP:0002579) | 1.83003218 |
| 145 | Hyperthyroidism (HP:0000836) | 1.82671600 |
| 146 | Intrahepatic cholestasis (HP:0001406) | 1.82057514 |
| 147 | Conjunctival hamartoma (HP:0100780) | 1.81633783 |
| 148 | Increased intramyocellular lipid droplets (HP:0012240) | 1.81513735 |
| 149 | Neuronal loss in central nervous system (HP:0002529) | 1.81218822 |
| 150 | Recurrent bacterial skin infections (HP:0005406) | 1.80910548 |
| 151 | Annular pancreas (HP:0001734) | 1.80639615 |
| 152 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80267027 |
| 153 | Large for gestational age (HP:0001520) | 1.78462001 |
| 154 | Agammaglobulinemia (HP:0004432) | 1.78135836 |
| 155 | Hypertriglyceridemia (HP:0002155) | 1.76346307 |
| 156 | Late onset (HP:0003584) | 1.74517986 |
| 157 | Deep venous thrombosis (HP:0002625) | 1.74189888 |
| 158 | Premature skin wrinkling (HP:0100678) | 1.73767971 |
| 159 | Hand muscle atrophy (HP:0009130) | 1.73677614 |
| 160 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.73560927 |
| 161 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.73507287 |
| 162 | Gingivitis (HP:0000230) | 1.73176057 |
| 163 | Premature rupture of membranes (HP:0001788) | 1.73168458 |
| 164 | Increased serum ferritin (HP:0003281) | 1.72698223 |
| 165 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72433152 |
| 166 | Palmoplantar keratoderma (HP:0000982) | 1.72255798 |
| 167 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70741860 |
| 168 | Lymphangioma (HP:0100764) | 1.70646576 |
| 169 | Turricephaly (HP:0000262) | 1.70250880 |
| 170 | Shallow orbits (HP:0000586) | 1.70201445 |
| 171 | Abnormality of the foot musculature (HP:0001436) | 1.67874004 |
| 172 | Long toe (HP:0010511) | 1.67839060 |
| 173 | Gastrointestinal stroma tumor (HP:0100723) | 1.67557022 |
| 174 | Lethargy (HP:0001254) | 1.67426570 |
| 175 | Hepatosplenomegaly (HP:0001433) | 1.66867114 |
| 176 | Bulbar palsy (HP:0001283) | 1.66349193 |
| 177 | Rectal prolapse (HP:0002035) | 1.66320009 |
| 178 | Sudden cardiac death (HP:0001645) | 1.64864223 |
| 179 | Lower limb amyotrophy (HP:0007210) | 1.64720242 |
| 180 | Myositis (HP:0100614) | 1.63304837 |
| 181 | Foot dorsiflexor weakness (HP:0009027) | 1.63300500 |
| 182 | Spinal canal stenosis (HP:0003416) | 1.63105470 |
| 183 | Abnormality of macular pigmentation (HP:0008002) | 1.62607210 |
| 184 | Microvesicular hepatic steatosis (HP:0001414) | 1.61890808 |
| 185 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.61619514 |
| 186 | Aneurysm (HP:0002617) | 1.61331561 |
| 187 | Vomiting (HP:0002013) | 1.61315350 |
| 188 | Hyperkalemia (HP:0002153) | 1.61187671 |
| 189 | Skin nodule (HP:0200036) | 1.58590679 |
| 190 | Rapidly progressive (HP:0003678) | 1.58249902 |
| 191 | Areflexia of lower limbs (HP:0002522) | 1.58005489 |
| 192 | Increased purine levels (HP:0004368) | 1.57899656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.25365128 |
| 2 | LMTK2 | 4.10628374 |
| 3 | PHKG1 | 3.31074968 |
| 4 | PHKG2 | 3.31074968 |
| 5 | SMG1 | 3.22824115 |
| 6 | TRIB3 | 3.04705366 |
| 7 | BCKDK | 2.94665749 |
| 8 | PKN2 | 2.86101522 |
| 9 | PRPF4B | 2.69943939 |
| 10 | WNK4 | 2.58587889 |
| 11 | MAP2K3 | 2.46972234 |
| 12 | OBSCN | 2.37460380 |
| 13 | MAP4K1 | 2.32839879 |
| 14 | NME2 | 2.27931905 |
| 15 | DMPK | 2.22533975 |
| 16 | PDK4 | 2.04978733 |
| 17 | PDK3 | 2.04978733 |
| 18 | MAP3K13 | 1.96650231 |
| 19 | MYLK | 1.87152630 |
| 20 | ICK | 1.86327363 |
| 21 | IRAK3 | 1.86140066 |
| 22 | MAP3K7 | 1.81201332 |
| 23 | TAOK3 | 1.75367100 |
| 24 | PINK1 | 1.75215938 |
| 25 | NEK1 | 1.73511239 |
| 26 | STK39 | 1.70710494 |
| 27 | MAP3K11 | 1.65260175 |
| 28 | TNK2 | 1.51984346 |
| 29 | KSR2 | 1.49264504 |
| 30 | WNK1 | 1.41777391 |
| 31 | RIPK4 | 1.41375351 |
| 32 | PRKD1 | 1.35415824 |
| 33 | TBK1 | 1.34791264 |
| 34 | TESK2 | 1.33983550 |
| 35 | PAK3 | 1.28340360 |
| 36 | PIK3CA | 1.25670120 |
| 37 | STK38 | 1.22861885 |
| 38 | MAP3K10 | 1.20438098 |
| 39 | ZAP70 | 1.19179476 |
| 40 | EPHB1 | 1.18662770 |
| 41 | RIPK1 | 1.18604565 |
| 42 | TYK2 | 1.18584297 |
| 43 | TAOK2 | 1.17228529 |
| 44 | PRKD3 | 1.14983103 |
| 45 | MAP3K6 | 1.14007250 |
| 46 | TESK1 | 1.10464158 |
| 47 | PAK6 | 1.08938155 |
| 48 | PRKAA1 | 1.08358711 |
| 49 | EPHA2 | 1.06120976 |
| 50 | BMX | 1.06021481 |
| 51 | MAP2K6 | 1.05791662 |
| 52 | IRAK4 | 1.05614569 |
| 53 | MAPK12 | 1.04425721 |
| 54 | PRKAA2 | 1.03346492 |
| 55 | CDC42BPA | 1.02768792 |
| 56 | CAMK2D | 1.02759557 |
| 57 | MAP3K14 | 1.02452249 |
| 58 | SIK1 | 1.02238808 |
| 59 | PDK2 | 1.01432807 |
| 60 | EPHA4 | 1.01111327 |
| 61 | JAK3 | 1.01078887 |
| 62 | CDK12 | 1.00630019 |
| 63 | RPS6KA2 | 0.98742253 |
| 64 | MAP3K3 | 0.96203197 |
| 65 | PDPK1 | 0.94480808 |
| 66 | RPS6KL1 | 0.94275676 |
| 67 | KDR | 0.94047761 |
| 68 | PKN1 | 0.93175116 |
| 69 | TAOK1 | 0.91565797 |
| 70 | CAMK1G | 0.90232435 |
| 71 | SIK3 | 0.88550203 |
| 72 | ERN1 | 0.87890257 |
| 73 | OXSR1 | 0.86476246 |
| 74 | PDGFRA | 0.85910703 |
| 75 | INSRR | 0.85187045 |
| 76 | BTK | 0.83307536 |
| 77 | TYRO3 | 0.82770014 |
| 78 | PAK4 | 0.81144718 |
| 79 | PRKCH | 0.80308208 |
| 80 | PTK6 | 0.79976630 |
| 81 | BLK | 0.79319156 |
| 82 | PDK1 | 0.78236755 |
| 83 | CAMK4 | 0.76790786 |
| 84 | ARAF | 0.76613586 |
| 85 | GRK6 | 0.76500680 |
| 86 | CDK4 | 0.76441778 |
| 87 | PRKD2 | 0.75860553 |
| 88 | EEF2K | 0.74671782 |
| 89 | MARK2 | 0.74069487 |
| 90 | CAMKK1 | 0.73554047 |
| 91 | RPS6KA6 | 0.70999798 |
| 92 | SGK3 | 0.70914735 |
| 93 | MAP2K4 | 0.70592060 |
| 94 | PTK2 | 0.68835056 |
| 95 | MAP3K4 | 0.68473217 |
| 96 | NTRK1 | 0.67868329 |
| 97 | STK11 | 0.66851599 |
| 98 | MST1R | 0.66550541 |
| 99 | MAPK15 | 0.66477853 |
| 100 | LRRK2 | 0.65045718 |
| 101 | FGFR4 | 0.63951768 |
| 102 | ROCK2 | 0.63950044 |
| 103 | IKBKE | 0.63126101 |
| 104 | MTOR | 0.62801891 |
| 105 | HIPK2 | 0.62711658 |
| 106 | SGK223 | 0.62350496 |
| 107 | SGK494 | 0.62350496 |
| 108 | DYRK1B | 0.61462779 |
| 109 | CSK | 0.61061484 |
| 110 | ROCK1 | 0.60536664 |
| 111 | CAMK1D | 0.58411160 |
| 112 | TIE1 | 0.57880629 |
| 113 | ALK | 0.57166079 |
| 114 | PIM2 | 0.57137987 |
| 115 | RPS6KB2 | 0.55878827 |
| 116 | UHMK1 | 0.54513348 |
| 117 | CAMK2A | 0.53324407 |
| 118 | PTK2B | 0.52970790 |
| 119 | MAP3K9 | 0.52769653 |
| 120 | IKBKB | 0.52439406 |
| 121 | FES | 0.52341077 |
| 122 | RET | 0.52101743 |
| 123 | MAP2K2 | 0.51568750 |
| 124 | ILK | 0.51506290 |
| 125 | CDK7 | 0.51376900 |
| 126 | MAP3K8 | 0.50928047 |
| 127 | IRAK2 | 0.50786764 |
| 128 | PRKACG | 0.50563055 |
| 129 | MAPK11 | 0.50252835 |
| 130 | CAMK1 | 0.49452888 |
| 131 | HCK | 0.49133737 |
| 132 | NME1 | 0.48305091 |
| 133 | GRK1 | 0.48033261 |
| 134 | MAPK7 | 0.47359235 |
| 135 | PRKACB | 0.47007974 |
| 136 | MAP3K1 | 0.46683367 |
| 137 | AKT2 | 0.45302209 |
| 138 | GRK7 | 0.45283850 |
| 139 | CAMK2G | 0.44723443 |
| 140 | DAPK3 | 0.44177346 |
| 141 | DAPK2 | 0.43922755 |
| 142 | RPS6KA1 | 0.43187207 |
| 143 | MUSK | 0.42183545 |
| 144 | MATK | 0.41322771 |
| 145 | RPS6KA3 | 0.41013351 |
| 146 | SIK2 | 0.40758313 |
| 147 | ITK | 0.40524284 |
| 148 | MAPKAPK2 | 0.39842948 |
| 149 | BRAF | 0.39294241 |
| 150 | WNK3 | 0.38849787 |
| 151 | SGK1 | 0.38766300 |
| 152 | PRKG2 | 0.37799760 |
| 153 | LCK | 0.36487622 |
| 154 | PRKACA | 0.36458406 |
| 155 | DDR2 | 0.35354356 |
| 156 | MAP3K2 | 0.33769864 |
| 157 | NTRK3 | 0.33735834 |
| 158 | MAPKAPK3 | 0.32887481 |
| 159 | JAK2 | 0.32763294 |
| 160 | RPS6KC1 | 0.30720074 |
| 161 | CSF1R | 0.30314504 |
| 162 | SYK | 0.30185598 |
| 163 | CHUK | 0.29882031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.05249265 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.81126968 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.76310037 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.58333669 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.87249503 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68964809 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61528465 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.54840301 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.39920300 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.35148936 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.34876632 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.25791555 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24860694 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10266945 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.09654647 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07125742 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.96157984 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.95050992 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94470323 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94194124 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.91656589 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.85060686 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.82271582 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.76382578 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.69221577 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.67935546 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66110093 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59069909 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56842180 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56439689 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52430300 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48938267 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.48498249 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44610487 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42980407 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41348461 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39986674 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38788669 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34866955 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34625565 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33881838 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.33392373 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.32947717 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30324727 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.27272485 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.27260763 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.27125564 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27011393 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.26326776 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26232344 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25486405 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23996773 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.23258855 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.18398956 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18354236 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.15629476 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13803986 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12577639 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11560532 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10924496 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09612011 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09107728 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07330962 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 1.05612055 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 1.03613483 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.03485414 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03110791 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02740064 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01750482 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01434682 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 1.01196569 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00598806 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99461911 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98657258 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97003443 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96708047 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.95966128 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.95804148 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95617102 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94876860 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.93154371 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92063129 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.91940933 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91594004 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91465779 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90501175 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.89763789 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88904364 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88586781 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.88552625 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85489600 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84111700 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82717510 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82223459 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81826398 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81533254 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80328351 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80215906 |
| 99 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79329105 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78124662 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77858850 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.77449407 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77392691 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75336436 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75235910 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74582381 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74268749 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73920603 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.73685521 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73496849 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73221995 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72903158 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72757332 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.72288119 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.71434220 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69707644 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67415110 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67070168 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65938981 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65224191 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64526083 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63903287 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.63208536 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.62262223 |
| 125 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61670645 |
| 126 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60316435 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60072930 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59747447 |
| 129 | DNA replication_Homo sapiens_hsa03030 | 0.58893031 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.57477293 |
| 131 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57330466 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.57275588 |
| 133 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57097670 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56566751 |
| 135 | Allograft rejection_Homo sapiens_hsa05330 | 0.56513938 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.56159028 |
| 137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54557034 |
| 138 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54100984 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53578140 |
| 140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53504179 |
| 141 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53039759 |
| 142 | Salivary secretion_Homo sapiens_hsa04970 | 0.52964648 |
| 143 | Focal adhesion_Homo sapiens_hsa04510 | 0.52456586 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51225197 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51167783 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.51137557 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49504553 |
| 148 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48990134 |
| 149 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47855369 |
| 150 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47845637 |
| 151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47584777 |
| 152 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46939867 |
| 153 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46586015 |
| 154 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46188116 |
| 155 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46062133 |
| 156 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45887104 |
| 157 | Malaria_Homo sapiens_hsa05144 | 0.45795498 |
| 158 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44997688 |
| 159 | Morphine addiction_Homo sapiens_hsa05032 | 0.44754627 |
| 160 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43142375 |
| 161 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42580762 |
| 162 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42408265 |
| 163 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42305817 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40114617 |
| 165 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39036459 |
| 166 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37456737 |
| 167 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35634521 |
| 168 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35238556 |
| 169 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.34387609 |
| 170 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33756640 |
| 171 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32954166 |
| 172 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32584341 |
| 173 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29165880 |
| 174 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28406802 |
| 175 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28230395 |
| 176 | Mineral absorption_Homo sapiens_hsa04978 | 0.27809763 |
| 177 | Tight junction_Homo sapiens_hsa04530 | 0.27637677 |
| 178 | Gap junction_Homo sapiens_hsa04540 | 0.24480899 |
| 179 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24397772 |

